168 related articles for article (PubMed ID: 26164397)
1. The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital.
Yang Y; Zhang XZ; Ng HS; Fong JC; Lee LH
Thromb Res; 2015 Sep; 136(3):548-51. PubMed ID: 26164397
[TBL] [Abstract][Full Text] [Related]
2. Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis.
Pincus KJ; Tata AL; Watson K
Ann Pharmacother; 2012 Jun; 46(6):873-8. PubMed ID: 22570429
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease.
Barclay SM; Jeffres MN; Nguyen K; Nguyen T
Pharmacotherapy; 2013 Apr; 33(4):375-82. PubMed ID: 23553808
[TBL] [Abstract][Full Text] [Related]
4. Family history of venous thromboembolism and risk of hospitalized thromboembolism in cancer patients: A nationwide family study.
Zöller B; Palmer K; Li X; Sundquist J; Sundquist K
Thromb Res; 2015 Sep; 136(3):573-81. PubMed ID: 26194121
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of venous thromboembolism prophylaxis in patients with chronic liver disease.
Smith CB; Hurdle AC; Kemp LO; Sands C; Twilla JD
J Hosp Med; 2013 Oct; 8(10):569-73. PubMed ID: 24101541
[TBL] [Abstract][Full Text] [Related]
6. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease.
Dabbagh O; Oza A; Prakash S; Sunna R; Saettele TM
Chest; 2010 May; 137(5):1145-9. PubMed ID: 20040609
[TBL] [Abstract][Full Text] [Related]
7. Risk of hemorrhage in patients with chronic liver disease and coagulopathy receiving pharmacologic venous thromboembolism prophylaxis.
Reichert JA; Hlavinka PF; Stolzfus JC
Pharmacotherapy; 2014 Oct; 34(10):1043-9. PubMed ID: 25052037
[TBL] [Abstract][Full Text] [Related]
8. A Retrospective Cohort Analysis of Pharmacologic VTE Prophylaxis and Padua Prediction Score in Hospitalized Patients With Chronic Liver Disease.
Moorehead KJ; Jeffres MN; Mueller SW
J Pharm Pract; 2017 Feb; 30(1):58-63. PubMed ID: 26475125
[TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism in patients with liver diseases.
Barba R; Gonzalvez-Gasch A; Joya Seijo D; Marco J; Canora J; Plaza S; Angelina García M; Zapatero A
J Thromb Haemost; 2018 Oct; 16(10):2003-2007. PubMed ID: 30066476
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for venous thromboembolism in patients with chronic liver disease.
Walsh KA; Lewis DA; Clifford TM; Hundley JC; Gokun Y; Angulo P; Davis GA
Ann Pharmacother; 2013 Mar; 47(3):333-9. PubMed ID: 23482730
[TBL] [Abstract][Full Text] [Related]
11. Contact isolation is a risk factor for venous thromboembolism in trauma patients.
Reed CR; Ferguson RA; Peng Y; Collier BR; Bradburn EH; Toms AR; Fogel SL; Baker CC; Hamill ME
J Trauma Acute Care Surg; 2015 Nov; 79(5):833-7. PubMed ID: 26496110
[TBL] [Abstract][Full Text] [Related]
12. Incidence and prevalence of venous thromboembolism in chronic liver disease: A systematic review and meta-analysis.
Subhani M; Sheth A; Ahmed J; Wijayasiri P; Gardezi SA; Enki D; Morling JR; Aithal GP; Ryder SD; Aravinthan AD
Thromb Res; 2022 Jul; 215():19-29. PubMed ID: 35594737
[TBL] [Abstract][Full Text] [Related]
13. Frequency and predictors of venous thromboembolism in orthotopic liver transplant recipients: a single-center retrospective review.
Salami A; Qureshi W; Kuriakose P; Moonka D; Yoshida A; Abouljoud M
Transplant Proc; 2013; 45(1):315-9. PubMed ID: 23267811
[TBL] [Abstract][Full Text] [Related]
14. Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.
Mahan CE; Fisher MD; Mills RM; Fields LE; Stephenson JJ; Fu AC; Spyropoulos AC
Thromb Res; 2013 Nov; 132(5):520-6. PubMed ID: 24080150
[TBL] [Abstract][Full Text] [Related]
15. [Incidence of venous thromboembolism in men admitted to a pneumology unit for acute respiratory disease].
Aissa I; Rachdi I; Ben Miled K; Ghedira H
Rev Pneumol Clin; 2011 Jun; 67(3):129-35. PubMed ID: 21665075
[TBL] [Abstract][Full Text] [Related]
16. Rates of venous thromboembolism occurrence in medical patients among the insured population.
Spyropoulos AC; Hussein M; Lin J; Battleman D
Thromb Haemost; 2009 Nov; 102(5):951-7. PubMed ID: 19888534
[TBL] [Abstract][Full Text] [Related]
17. Hospital-associated venous thromboembolism in children: incidence and clinical characteristics.
Takemoto CM; Sohi S; Desai K; Bharaj R; Khanna A; McFarland S; Klaus S; Irshad A; Goldenberg NA; Strouse JJ; Streiff MB
J Pediatr; 2014 Feb; 164(2):332-8. PubMed ID: 24332452
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology, risk and outcomes of venous thromboembolism in cancer.
Falanga A; Russo L
Hamostaseologie; 2012; 32(2):115-25. PubMed ID: 21971578
[TBL] [Abstract][Full Text] [Related]
19. Risk-assessment and pharmacological prophylaxis of venous thromboembolism in hospitalized patients with chronic liver disease.
Bogari H; Patanwala AE; Cosgrove R; Katz M
Thromb Res; 2014 Dec; 134(6):1220-3. PubMed ID: 25294587
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.
Bergmann JF; Cohen AT; Tapson VF; Goldhaber SZ; Kakkar AK; Deslandes B; Huang W; Anderson FA;
Thromb Haemost; 2010 Apr; 103(4):736-48. PubMed ID: 20135072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
